308-nm excimer laser plus topical calcipotriol in the treatment of vitiligo

Phase 2

• Conditions: Vitiligo.; Vitiligo

• Registration Number: IRCT138808212704N1
• Lead Sponsor: Research department of medical school of Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

The patients that suffer from localized or generalized vitiligo at least for one year or stable vitiligo, All the phenotypes of skin color. Exclusion criterion: Pregnancy, Lactation, Allergy to calcipotriol, Renalinsufficiency, Abnormality in bone or calcium metabolism, Light-sensitive dermatoses, Photodermatoses, Phototoxic systemic or topical medication, Previous history of arsenic exposure, Excessive exposure to UV light, Previous history of skin cancer.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Repigmentation. Timepoint: first visit,12 weeks after starting therapy. Method of measurement: Visual scale software.

Secondary Outcome Measures

Name	Time	Method
Irritant contact dermatitis. Timepoint: 2 times per week(in each phototherapy session). Method of measurement: clinical examination.